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Summary 
Signalling in apoptosis and inflammation is often mediated by proteins of the death 
domain superfamily in the Fas/FADD/Caspase-8 or the Apaf-1/Caspase-9 
pathways. This superfamily currently comprises the death domain (DD), death 
effector domain (DED), caspase recruitment domain (CARD), and pyrin domain 
(PYD) subfamilies . The PYD subfamily is most abundant, but three-dimensional 
structures are only available for the subfamilies DD, DED and CARD, which have 
an antiparallel arrangement of six α-helices as common fold. This paper presents 
the NMR structure of PYD of NALP1, a protein that is involved in the innate 
immune response and is a component of the inflammasome. The structure of 
NALP1 PYD differs from all other known death domain superfamily structures in 
that the third α-helix is replaced by a flexibly disordered loop. This unique feature 
appears to relate to the molecular basis of familial Mediterranean fever (FMF), a 
genetic disease caused by single point mutations. 
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Introduction 
Apoptosis and inflammation are two closely related processes in the cells of 
higher organisms. Signal transduction and protein oligomerization in both apoptosis and 
inflammation are often mediated by a group of protein−protein interaction domains, the 
death domain superfamily (Hengartner, 2000; Weber et al., 2001). The death domain 
superfamily currently comprises four subfamilies, the death domain (DD), the death 
effector domain (DED), the caspase recruitment domain (CARD) and the pyrin domain 
(PYD or PAAD, DAPIN, PLM, PYRN, PyK) (Bertin et al., 2000; Martinon et al., 2001; 
Staub et al., 2001). After its discovery in the protein pyrin (or marenostrin) (The French 
FMF Consortium, 1997; The International FMF Consortium, 1997), PYD was 
recognized to be a fourth member of the death domain superfamily, based on sequence 
alignments, secondary structure predictions and homology modelling (Bertin et al., 
2000; Martinon et al., 2001; Staub et al., 2001). So far, only protein–protein interactions 
between members of the same DD subfamily have been observed, i.e., PYD–PYD, DD–
DD, CARD–CARD and DED–DED interactions, indicating high specificity of the 
binding mechanisms between death domain superfamily members (Weber et al., 2001). 
Examples are the Fas/FADD/Caspase-8, the TNF-R/RAIDD/RIP or the Apaf-
1/Caspase-9 pathways. Even though PYD is the most abundant subfamily of all the 
death domain superfamily members, structural information is only available for the DD, 
DED and CARD domains (Huang et al., 1996; Eberstadt et al., 1998; Zhou et al., 1999; 
Berglund et al., 2000). All reported structures of the death domain superfamily share an 
antiparallel arrangement of six α-helices as a common fold. The lengths and the relative 
orientations of the six helices vary between the individual structures, but the overall 
topology, termed the death domain fold, is conserved. 
4 
NALP1 (DEFCAP, CARD7, NAC) (Hlaing et al., 2001; Chu et al., 2001) is a 
multidomain protein involved in inflammation and apoptosis. It is composed of a N-
terminal PYD, a NACHT (domain present in neuronal apoptosis inhibitory protein 
(NAIP), the major histocompatibility complex (MHC), class II transactivator (CIITA), 
HET-E, TP1) (Koonin et al., 2000), a NAD (NACHT associated domain), a LRR 
(leucine rich repeat) and a CARD domain at the C-terminus (Tschopp et al., 2003). This 
multidomain architecture is shared by many other proteins (e.g., Apaf-1) and they are 
now classified as CATERPILLAR proteins (Harton et al., 2002). NALP1 interacts with 
ASC (apoptosis-associated speck-like protein containing a CARD) (Martinon et al., 
2001; Masumoto et al., 1999) via PYD, and with procaspase-5 via the C-terminal 
CARD. These proteins, together with procaspase-1 form the “inflammasome”, a 700 
kDa multiprotein-complex (Martinon et al., 2002). The stoichiometry of the proteins in 
the inflammasome is not known, but the inflammasome has been shown to activate 
procaspase-1, which ultimately processes the potent endogenous pyrogen IL-1β from its 
precursor pro-IL-1β (Μartinon et al., 2002). Single-point mutations in CATERPILLER 
proteins can have severe consequences. Examples are the development of 
autoinflammatory diseases, such as familial cold autoinflammatory syndrome (FCAS) 
or Muckle-Wells syndrome (MWS) upon mutations in cryopyrin (NALP3, PYPAF1) 
(Kastner et al., 2001), and familial Mediterranean fever (FMF) upon mutations in pyrin 
(The French FMF Consortium, 1997; The International FMF Consortium, 1997). One of 
these FMF associated point mutations, R42W, is located in the PYD domain of pyrin 
(Hull et al., 2003). 
We have been able to express, solubilize and purify the full length PYD domain of 
NALP1, and in this paper we present its NMR structure. The structure differs 
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significantly from the death domain superfamily fold, as the third α-helix is replaced by 
a flexibly disordered loop. This difference is of high importance, especially because the 
third helix can play a critical role in protein−protein interactions within the death 
domain superfamily (Weber et al., 2001; Kaufmann et al., 2002). A sequence alignment 
of several PYD domains reveals further structural features relevant for the 
protein−protein interactions, and allows locating the FMF associated point mutation in 
the PYD of pyrin in the flexible loop replacing the third α-helix. 
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Results and Discussion 
Protein expression and purification 
As an isolated domain, NALP1 PYD aggregates at concentrations above 10 µM. 
Therefore we used a two-domain fusion protein of the full-length NALP1 PYD and a 
56-residue G B1 solubility enhancing tag (Zhou et al., 2001), which could be 
concentrated in the mM range for NMR experiments (see Experimental Procedures). 
The NMR structure of NALP1 PYD 
The NMR structure of NALP1 PYD (Table 1, Fig. 1 and Fig. 2) consists of a 
tightly packed arrangement of five α-helices (Fig. 1 b), connected by three short linkers 
of non-regular secondary structure, and a long flexibly disordered polypeptide segment 
connecting the second and third α-helices. The five helices comprising the residues 
8−13, 18−30, 51−59, 63−76 and 80−85 are numbered 1, 2, 4, 5 and 6 to maintain 
consistency with the 6-helix death domain superfamily fold. The surface of NALP1 
PYD shows a large negatively charged patch consisting of E19 and E20 (Fig. 1 c), 
which turns out to be a common trait of PYD domains (see below). 
Evidence for the flexibly disordered loop 
For the polypeptide segment between the helices 2 and 4, no long-range NOEs to 
protons in the remaining part of the domain were observed. This is reflected in the low 
precision of the structure determination in this region (Fig. 1 a). The flexible nature of 
the structural disorder was confirmed by measurements of heteronuclear 15N{1H}–
NOEs (Fig. 3 a), which showed that the effective rotational correlation time for residues 
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in this loop is significantly shorter than in the other parts of the protein. The 13C 
chemical shift deviations for Cα and Cβ atoms from random coil values (Fig. 3 b) show 
large positive values for the five α-helices, whereas the linkers between the helices and 
especially the loop between α2 and α4 show only small deviations, indicating non-
regular secondary structure. In this context, it is noteworthy that the T41−P42 peptide 
bond appears to undergo cis-trans isomerization (Wüthrich et al., 1984): In the [15N,1H]-
COSY spectrum the residues flanking P42 show resonance signals for a second species, 
with an abundance of about 10%. 
The PYD subfamily 
In the genome of Homo sapiens, 18 PYDs have been described so far (Harton et 
al., 2002; Tschopp et al., 2003), and for 12 of them, i.e., NALP 1, 2, 4, 5, 6, 7, 11 and 
12, cryopyrin, pyrin, ASC and ASCII, the amino acid sequence has been published in 
the SWISS-PROT database. These sequences can be aligned for a high degree of 
homology (Fig. 4 a), whereby four residues are strictly conserved in all 12 PYDs. These 
are the aforementioned P42 in the loop linking α2 and α4, and the hydrophobic residues 
L13, L16 and F24, which are part of the protein core. Residues 9, 21, 28, 53, 57, 74 and 
77 are conserved hydrophobic residues in all 12 PYDs, which are also part of the 
hydrophobic core of the domain (Fig. 4 a), suggesting that a similar fold to NALP1 
PYD can be expected for the other PYDs as well. Further conserved features are located 
on the surface of the domain, where two acidic and one basic regions are present in all 
12 PYDs. These include E14, which is conserved in all PYDs except NALP5, which 
instead contains E15 (Fig. 4 a). Further, residue 20 is acidic in all sequences except 
NALP6, where residue 19 is acidic. In 7 out of the 12 sequences, the residues 19 and 20 
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are both acidic, which includes NALP1 PYD (Fig. 1 c). The conserved basic patch is a 
cluster of the four sidechains of residues 22, 23, 25 and 47, which are closely spaced in 
NALP1 PYD. In all 12 PYDs, these four residues have polar sidechains. Residue 25 is 
basic in all but one of the proteins, in each sequence the cluster carries at least one 
positive charge, and in eight of the PYDs there are 3 or 4 positive charges. Similar 
alignments of DDs, DEDs and CARDs showed no comparable degree of conservation 
within each of these families (data not shown). 
Pyrin PYD and the molecular basis of FMF 
As mentioned above, the amino acid exchange R42W in the PYD-domain of pyrin 
presents with FMF, a disease that causes ongoing episodes of inflammatory attacks to 
the patient. Residue R42 of the pyrin PYD-domain corresponds to residue A43 in the 
structure of NALP1 PYD. The location of this amino acid in the flexible loop, next to 
the conserved P42 and the conserved basic surface patch (yellow in Fig. 4 a), suggests 
that this part of the domain is involved in protein–protein interactions that trigger 
apoptosis or inflammation. The conserved acidic regions might further promote contacts 
via intermolecular saltbridges with the basic patch of another PYD. It seems even 
conceivable that the loop between the helices 2 and 4 might adopt a helical structure 
upon complex formation. In another scenario, the loop 3 could be structured and 
become α-helical by an intra-protein domain-domain interaction which might play a 
role in the assembly or regulation of NALP1. However no evidence for any of these 
possibilities was found. Our experiments show no secondary structure and no contacts 
between residues in the loop 3 and residues in the rest of the PYD (see evidence for the 
flexibly disordered loop). 
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Comparison of the four death domain subfamilies 
A structural comparison between members of the four subfamilies of the death 
domain superfamily (Fig. 4 b) shows similarities and differences. Common to all four 
structures is the spatial arrangement of the α-helices 1, 2, 4, 5 and 6. They have slightly 
different tilt angles with respect to each other in the four structures, but the overall 
topology is the same. A striking difference is the absence of α-helix 3 in NALP1 PYD, 
which makes it unique in the death domain superfamily. This variation has also been 
observed in a mutant form of the Fas DD, the “proliferation mutant”, where the single-
point mutation V238N causes the α-helix 3 to unfold. Val 238, which is located in the 
loop connecting the α-helices 2 and 3, forms hydrophobic interactions with Val 233 of 
α2, Ile 243 of α 3, and Leu 268 and Trp 265 of α4. Replacement of Val 238 by Asn 
disrupts these hydrophobic interactions, resulting in the unfolding of α-helix 3 
(Eberstadt et al., 1997). Mice carrying this variant gene present with lymphadenopathy 
and suffer from a systemic autoimmune disease (Watanabe-Fukunaga et al., 1992). 
However, all wild type structures of DDs, DEDs or CARDs reported so far include the 
α-helix 3. At this stage, it is not clear whether the flexible loop is a general feature of all 
PYDs. When compared to the other death domain subfamilies, NALP1 PYD lacks 
hydrophobic residues in the loop polypeptide segment linking α2 and α4, which is not 
true for other PYDs. Whether the presence of some hydrophobic sidechains would be 
sufficient to induce a regular secondary structure in the place of the flexible loop cannot 
be decided based on the available data. Secondary structure predictions applied to the 
PYD consensus sequence have come to contradictory results with regard to the 
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polypeptide segment corresponding to the α-helix 3 in the other death domains 
(Martinon et al., 2001; Staub et al., 2001). 
Conclusions 
In conclusion, the three-dimensional structure of a PYD-domain shows that the 
fold of NALP1 PYD is locally different from the known death domain superfamily 
folds in the region between the α-helices 2 and 4. This observation motivates further 
studies, to investigate whether the absence of α-helix 3 is a general feature of all PYDs. 
If this were the case, PYD should be considered to form a new subgroup of the death 
domain superfamily, with the DD, DED and CARD domains all belonging to another 
subgroup. The structure of NALP1 PYD allows insight into possible interactions 
between multiple PYDs, and provides a molecular model visualizing mutation sites that 
present with genetic fever diseases. It could thus also become a target for drug 
discovery projects in the area of inflammation. 
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Experimental Procedures 
Cloning and Protein expression 
The NALP1 PYD gene (aa 1–92) was subcloned from the full length Nalp1 and 
inserted into a pET20b+ (Novagen) derived vector, which contained an N-terminal G 
B1 expression and solubility enhancer with a C-terminal 6-His tag (Zhou et al., 2001). 
For the NMR experiments, 13C, 15N uniformly labelled protein was obtained by using 
the BL21(DE3) (Novagen) E. coli expression strain and a standard M9 minimal medium 
prepared with 15NH4Cl and with [13C6]-glucose. The degree of isotope labelling of the 
protein after purification was confirmed to be >95% using ESI-MS. 
Sample preparation 
The protein was purified using a Ni-NTA affinity column (Quiagen) followed by 
a size exclusion column (sephadex 75, 26/60, Pharmacia). The NMR sample used for 
the structure determination was prepared at pH 6.5 in 95% H2O / 5% D2O containing 50 
mM Na2HPO4, 50 mM NaCl, 1 mM CHAPS, 20 mM [2H10]-DTT (Martek), 0.02 % 
NaN3, 0.1 mM EDTA and a protease inhibitor cocktail (Roche, Complete). The 
concentration of NALP1 PYD was approximately 1 mM. 
NMR data collection 
All NMR data recorded for the structure determination were performed on the 
same sample at 20° C on Bruker DRX 600 or DRX 750 spectrometers. For the 
resonance assignment the following standard experiments were recorded: 3D HNCA, 
3D HNCACB, 3D constant-time-HNCA, 3D CBCA(CO)NH, 3D HC(C)H-TOCSY, 3D 
HC(C)H-COSY (Wider, 1998). Distance constraints were obtained from three NOESY 
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experiments with mixing times of 60 ms, i.e., 3D 15N-resolved [1H,1H]-NOESY, and 3D 
13C-resolved [1H,1H]-NOESY with the 13C carrier frequency in the aliphatic and 
aromatic region, respectively. The data sets used for obtaining the sequence-specific 
resonance assignments were interactively peak-picked using the programs XEASY 
(Bartels et al., 1995) and CARA (in-house software, unpublished). Measurements of 
heteronuclear NOEs were performed at 20° C on a Bruker DRX 500 spectrometer 
equipped with a cryoprobe. The NOE spectrum and the reference spectrum were 
integrated using CARA. Error bars have been calculated from the spectral noise and the 
combination of two independently recorded experiments. For Fig. 3 b, a 1-2-1 weighted 
three-point smoothing function was applied to the raw data for the presentation of the 
Cα/Cβ chemical shift deviations from the random coil values. 
Structure calculation 
The aforementioned three NOESY spectra were picked and assigned with the 
automated NOESY peak picking and NOE assignment method ATNOS/CANDID 
(Herrmann et al., 2002a; 2002b) in the program DYANA (Güntert et al., 1997). The 
input for the iterative ATNOS/CANDID approach consisted of the chemical shift lists 
obtained from the sequence-specific resonance assignment, and the three NOESY 
spectra. ATNOS performs multiple cycles of NOE peak identification in conjunction 
with automated NOE assignment by the CANDID algorithm, and in the present 
implementation, structure calculation with the program DYANA. At the outset of the 
NOESY spectral analysis, the NOESY peak picking and NOE identification algorithm 
ATNOS makes use of the chemical shifts available from the independently obtained 
sequence-specific resonance assignment, and in more advanced stages of the calculation 
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also of the intermediate three-dimensional protein structure. Seven cycles of automated 
NOESY peak picking and NOE identification with ATNOS, automated NOE 
assignment with CANDID and subsequent structure calculation with the torsion angle 
dynamics algorithm of DYANA were performed. During the first six ATNOS/CANDID 
cycles, ambiguous distance constraints were used. 158 dihedral angle constraints for the 
backbone angles φ and ψ derived from Cα chemical shifts were added to the input for 
each cycle of the structure calculation. For the final structure calculation in 
ATNOS/CANDID cycle 7, a total of 4436 NOESY cross peaks were retained that could 
be unambiguously rationalized with the three-dimensional protein structure obtained in 
the ATNOS/CANDID cycle 6, leading to a total of 2088 meaningful NOE upper 
distance limits. The 20 conformers from the ATNOS/CANDID cycle 7 with the lowest 
final DYANA target function values were energy-minimized in a water shell with the 
program OPALp (Luginbühl et al., 1996). The program MOLMOL (Koradi et al., 1996) 
was used to analyze the resulting 20 energy-minimized conformers and to prepare the 
figures showing molecular models. 
Use of structure data bases and sequence alignment 
The amino acid sequences of the 12 PYDs in Fig. 4 a have been taken from the 
SWISS-PROT database. The sequence alignment was done using ClustalW (Higgins et 
al., 1994). Coordinates for the domains Apaf-1 CARD (Zhou et al., 1999), Fadd DD 
(Berglund et al., 2000) and Fadd DED (Eberstadt et al., 1998) have been taken from the 
PDB Protein Data Bank. 
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Figure 1 NMR structure of the NALP1 PYD-domain (residues 6 to 89 are 
shown). a, The polypeptide backbone represented by a bundle of 20 energy-
minimized DYANA (Güntert et al., 1997) conformers. The chain ends are 
identified by the letters N and C. b, Ribbon drawing of one of the 20 energy-
minimized conformers. α1, α2 and α4–α6 identify the five α-helices. c, Surface 
view of the same conformer as in b. Relative to panels a and b, the structure 
has been rotated by 45 degrees around a vertical axis, and is shown in the 
same orientation as in Fig. 4 a. Acidic regions of the surface are painted red, 
basic regions are painted blue. Arrows indicate the locations of the residues 
E19 and E20. 
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Figure 2 Stereoview of the same conformer as in Fig. 1b (residues 6 to 89 are 
shown). The polypeptide backbone is drawn in blue. Cα atoms with the residue 
number being a multiple of 10 are represented by red balls, all other Cα atoms 
by yellow balls. The chain ends are identified by the letters N and C. 
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Figure 3 Experiments showing that NALP1 PYD is flexibly unstructured 
between helices α2 and α4. a, Heteronuclear 15N{1H}-NOE measurements. 
Values between 0.5 and 1 indicate rigid parts of the protein, values <0.5 
manifest increased flexibility. b, Differences between the 13Cα and 13Cβ chemical 
shifts measured for NALP1 PYD and the corresponding random coil values. 
Values >2.5 are typical for α-helical residues. The locations of regular 
secondary structures in NALP1 PYD are shown below panel a. 
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Figure 4 Structural analysis of the PYD family. a, Sequence alignment of the 
PYD domains from 12 Homo sapiens proteins. The residue numbering of 
NALP1 PYD is given at the top. Common features of the 12 PYDs are identified 
by colouring and by a marker below the sequences: Strictly identical residues 
(dark green or violet, one-letter code of the conserved amino acid), 
conservation of polar residues (light blue, p), hydrophobic residues (light green, 
a), residues 14 and 20 (red, –), residue 25 (dark blue, +). The bottom line 
indicates the location of the α-helices (H) in the structure of NALP1 PYD. On 
the right, the conserved residues are visualized in the structure of NALP1 PYD, 
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using the same colour code as in the sequences. In addition, residue A43 is 
displayed in yellow (see text). b, Folds of the death domain superfamily. For 
each of the four subfamilies, a member is shown in the ribbon representation: 
Apaf-1 CARD (Zhou et al., 1999), Fadd DD (Berglund et al., 2000), Fadd DED 
(Eberstadt et al., 1998) and NALP1 PYD. The helices have been coloured as 
follows: α1 and α2 violet, α3 and α4 blue, α5 and α6 pink.  
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Table 1 Input for the structure calculation and characterization of the 
energy-minimized NMR structure of NALP1 PYD 
 
Quantity Value 
NOE upper distance limits 
Dihedral angle constraints 
2088 
158 
Residual DYANA target function value (Å2)* † 
Residual NOE distance limit violations* 
          Number ≥ 0.1 Å 
          Maximum (Å) 
1.79 ± 0.66 
 
32 ± 5 
0.15 ± 0.01 
AMBER energies, kcal/mol* 
          Total 
          van der Waals 
          Electrostatic 
 
-5963.66 ± 163.61 
-423.91± 28.88 
-6852.28 ± 146.62 
rmsd from ideal geometry* 
          Bond lengths, (Å) 
          Bond angles (degrees) 
 
0.0074 ± 0.0002 
1.95 ± 0.06 
rmsd from the mean coordinates (Å)‡ 
         bb G B1 (all 56 residues) 
         ha G B1 (all 56 residues) 
         bb NALP1 PYD (7–32, 47–87) 
         ha NALP1 PYD (7–32, 47–87) 
 
0.58 ± 0.11 
1.11 ± 0.14 
0.55 ± 0.08 
1.20 ± 0.14 
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Ramachandran plot statistics§ 
         Most favored regions (%) 
         Additional allowed regions(%) 
         Generously allowed regions (%) 
         Disallowed regions (%) 
 
76 
20 
3 
1 
*The numbers given are the average value ± the standard deviation for the set of 20 energy-
minimized conformers used to represent the NMR structure of the complete construct of G B1 + 
NALP1 PYD. 
†Before energy minimization. 
‡The rmsd values (average ± standard deviation for the bundle of 20 conformers) were 
calculated separately for the G B1 domain and for NALP1 PYD. bb indicates the backbone 
atoms N, Cα, C', and ha stands for all heavy atoms; the numbers in parentheses indicate the 
residues for which the rmsd was calculated. 
§ As determined by PROCHECK (Laskowski et al., 1996) 
